Clinical Trial Update: Avastin for Post-photocoagulation Macular Edema [Phase 4]

View source ↗

Summary

A Phase 4 trial of bevacizumab (Avastin) for macular edema after photocoagulation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Macular Edema | Phase 4 | Status: WITHDRAWN